Preclinical investigation of β-caryophyllene as a therapeutic agent in an experimental murine model of Dravet syndrome

1. Alonso, C.
2. Satta, V.
3. Díez-Gutiérrez, P.
4. Fernández-Ruiz, J.
5. Sagredo, O.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/J.NEUROPHARM.2021.108914 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

• 

Data source: Scopus